| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 672140 | Null | 0.0212053315848711 | 0.35544375 |
| NSC 672304 | Null | 0.0212053315848711 | 0.43607939 |
| NSC 682996 | Null | 0.0212053315848711 | 0.36745541 |
| NSC 686554 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- | 0.0212053315848711 | 0.067954975 |
| NSC 726089 | 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate | 0.0212053315848711 | 0.49961917 |
| NSC 726217 | Combretastatin A4-analogue | 0.0212053315848711 | 0.22053422 |
| NSC 726442 | 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride | 0.0212053315848711 | 0.29536401 |
| NSC 732962 | 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone | 0.0212053315848711 | 0.082446459 |
| NSC 744688 | Null | 0.0212053315848711 | 0.30409544 |
| NSC 748902 | [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] | 0.0212053315848711 | 0.3275072 |